Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
Blood Cancer Journal, Published online: 05 March 2024; doi:10.1038/s41408-024-01003-zTeclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 5, 2024 Category: Hematology Authors: Meera Mohan Jorge Monge Nishi Shah Danny Luan Mark Forsberg Vineel Bhatlapenumarthi Metodi Balev Anannya Patwari Heloise Cheruvalath Divaya Bhutani Sharmilan Thanendrarajan Binod Dhakal Maurizio Zangari Samer Al-Hadidi Dennis Cooper Suzanne Lentzsch Frits Source Type: research
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study
Blood Cancer Journal, Published online: 05 March 2024; doi:10.1038/s41408-024-01023-9Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - March 5, 2024 Category: Hematology Authors: Zimu Gong Godsfavour Umoru Jorge Monge Nishi Shah Ghulam Rehman Mohyuddin Sabarinath Venniyil Radhakrishnan Rajshekhar Chakraborty Leo Rasche Carolina Schinke Anita D ’Souza Meera Mohan Source Type: research
Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry
Blood Cancer Journal, Published online: 29 February 2024; doi:10.1038/s41408-024-01002-0Dual T-cell constant β chain (TRBC)1 and TRBC2 staining for the identification of T-cell neoplasms by flow cytometry (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 29, 2024 Category: Hematology Authors: Pedro Horna Matthew J. Weybright Mathieu Ferrari Dennis Jungherz YaYi Peng Zulaikha Akbar F. Tudor Ilca Gregory E. Otteson Jansen N. Seheult Janosch Ortmann Min Shi Paul M. Maciocia Marco Herling Martin A. Pule Horatiu Olteanu Source Type: research
Update on the management of relapsed/refractory chronic lymphocytic leukemia
Blood Cancer Journal, Published online: 21 February 2024; doi:10.1038/s41408-024-01001-1Update on the management of relapsed/refractory chronic lymphocytic leukemia (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 21, 2024 Category: Hematology Authors: Rory Bennett John F. Seymour Source Type: research
Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND)
Blood Cancer Journal, Published online: 20 February 2024; doi:10.1038/s41408-024-01000-2Comparing venetoclax in combination with hypomethylating agents to hypomethylating agent-based therapies for treatment naive TP53-mutated acute myeloid leukemia: results from the Consortium on Myeloid Malignancies and Neoplastic Diseases (COMMAND) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 20, 2024 Category: Hematology Authors: Talha Badar Ahmad Nanaa Ehab Atallah Rory M. Shallis Sacchi de Camargo Correia Guilherme Aaron D. Goldberg Antoine N. Saliba Anand Patel Jan P. Bewersdorf Adam S. DuVall Danielle Bradshaw Yasmin Abaza Guru Subramanian Guru Murthy Neil Palmisiano Amer M. Z Source Type: research
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial
Blood Cancer Journal, Published online: 19 February 2024; doi:10.1038/s41408-024-00990-3Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 19, 2024 Category: Hematology Authors: Eolia Brissot Myriam Labopin Helene Labussi ère Gaelle Fossard Patrice Chevallier Thierry Guillaume Ibrahim Yakoub-Agha Micha Srour Claude-Eric Bulabois Anne Huynh Sylvain Chantepie Anne-Lise Menard Marie-Therese Rubio Patrice Ceballos R émy Dulery Sabi Source Type: research
Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems
Blood Cancer Journal, Published online: 14 February 2024; doi:10.1038/s41408-024-00998-9Prognostic value of ferritin in ASCT MM patients: integration with GEP models and ISS series systems (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 14, 2024 Category: Hematology Authors: Wancheng Guo Yihao Zhan David Mery Eric R. Siegel Fumou Sun Yan Cheng Timothy Cody Ashby Zijun Zhang Clyde Bailey Daisy V. Alapat Hongling Peng Samer Al Hadidi Sharmilan Thanendrarajan Carolina Schinke Maurizio Zangari Frits van Rhee Guido Tricot John D. Source Type: research
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma
Blood Cancer Journal, Published online: 13 February 2024; doi:10.1038/s41408-024-00999-8Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 13, 2024 Category: Hematology Authors: Danmei Xu Findlay Bewicke-Copley Karina Close Jessica Okosun Robert Peter Gale Jane Apperley David M. Weinstock Hans-Guido Wendel Jude Fitzgibbon Source Type: research
Neutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study
Blood Cancer Journal, Published online: 09 February 2024; doi:10.1038/s41408-024-00994-zNeutrophil-to-lymphocyte ratio and all-cause mortality with and without myeloproliferative neoplasms—a Danish longitudinal study (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 9, 2024 Category: Hematology Authors: Morten Kranker Larsen Vibe Skov Lasse Kj ær Christina Schjellerup Eickhardt-Dalb øge Trine Alma Knudsen Marie Hvelplund Kristiansen Anders Lindholm S ørensen Troels Wienecke Morten Andersen Johnny T. Ottesen Johanne Gudmand-H øyer Jordan Andrew Snyder Source Type: research
Bispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas
Blood Cancer Journal, Published online: 08 February 2024; doi:10.1038/s41408-024-00997-wBispecific antibodies and CAR-T cells: dueling immunotherapies for large B-cell lymphomas (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 8, 2024 Category: Hematology Authors: Asaad Trabolsi Artavazd Arumov Jonathan H. Schatz Source Type: research
Efficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity
Blood Cancer Journal, Published online: 06 February 2024; doi:10.1038/s41408-024-00988-xEfficacy and immune modulation associated with the addition of IMiDs to Daratumumab backbone in multiple myeloma patients refractory to both drug classes: resetting synergistic activity (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 6, 2024 Category: Hematology Authors: Ioannis V. Kostopoulos Despina Fotiou Maria Gavriatopoulou Pantelis Rousakis Ioannis Ntanasis-Stathopoulos Chrysanthi Panteli Panagiotis Malandrakis Magdalini Migkou Nikolaos Angelis Nikolaos Kanellias Evangelos Eleutherakis-Papaiakovou Foteini Theodoraka Source Type: research
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM)
Blood Cancer Journal, Published online: 05 February 2024; doi:10.1038/s41408-024-00981-4Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM) (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 5, 2024 Category: Hematology Authors: Christopher P. Mill Warren C. Fiskus Courtney D. DiNardo Patrick Reville John A. Davis Christine E. Birdwell Kaberi Das Hanxi Hou Koichi Takahashi Lauren Flores Xinjia Ruan Xiaoping Su Sanam Loghavi Joseph D. Khoury Kapil N. Bhalla Source Type: research
GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review
Blood Cancer Journal, Published online: 02 February 2024; doi:10.1038/s41408-023-00966-9GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - February 2, 2024 Category: Hematology Authors: Paula Rodriguez-Otero Niels W. C. J. van de Donk Kodandaram Pillarisetti Ingrid Cornax Deeksha Vishwamitra Kathleen Gray Brandi Hilder Jaszianne Tolbert Thomas Renaud Tara Masterson Christoph Heuck Colleen Kane Raluca Verona Philippe Moreau Nizar Bahlis A Source Type: research
Bi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00989-wBi- and Tri-specific antibodies in non-Hodgkin lymphoma: current data and perspectives (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Iman Abou Dalle Remy Dulery Nour Moukalled Laure Ricard Nicolas Stocker Jean El-Cheikh Mohamad Mohty Ali Bazarbachi Source Type: research
Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review
Blood Cancer Journal, Published online: 25 January 2024; doi:10.1038/s41408-024-00985-0Alterations in chromosome 1q in multiple myeloma randomized clinical trials: a systematic review (Source: Blood Cancer Journal)
Source: Blood Cancer Journal - January 25, 2024 Category: Hematology Authors: Karun Neupane Gliceida Galarza Fortuna Riyasha Dahal Timothy Schmidt Rafael Fonseca Rajshekhar Chakraborty Kelly Ann Koehn Meera Mohan Hira Mian Luciano J. Costa Douglas Sborov Ghulam Rehman Mohyuddin Source Type: research
